In March 2022, the General Office of the State Council issued the "14th Five-Year Plan for the Development of Traditional Chinese Medicine" (hereinafter referred to as the "Plan") to comprehensively deploy the work of traditional Chinese medicine during the "14th Five-Year Plan" period, and in the chapter on promoting the high-quality development of the traditional Chinese medicine industry, the Plan proposes:
1. Strengthen the protection and utilization of traditional Chinese medicine resources;
2. Strengthen the production and management of authentic medicinal materials;
3. Improve the development level of traditional Chinese medicine industry;
4. Strengthen the safety supervision of traditional Chinese medicine. In the same month, National Medical Products Administration, the Ministry of Agriculture and Rural Affairs, the State Forestry and Grass Administration, and the State Administration of Traditional Chinese Medicine jointly issued the "Standards for the Production Quality Management of Chinese Medicinal Materials" (hereinafter referred to as the "Specifications") to encourage Chinese medicine manufacturers to build and build their own Chinese medicine production in the production area of Chinese medicinal materials. The "Specifications" Chinese medicine production enterprises and production bases extend the drug quality management system to the origin of Chinese medicinal materials; encourage Chinese medicine production enterprises to give priority to the use of Chinese medicinal materials that meet the requirements, promote the standardized production of Chinese medicinal materials, ensure the quality of Chinese medicinal materials, and promote the high-quality development of Chinese medicinal materials.